<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Marothia M</submitter><funding>Science and Engineering Research Board</funding><funding>Indian Council of Medical Research</funding><funding>Ministry of Education and Science of the Russian Federation</funding><funding>Department of Biotechnology, Ministry of Science and Technology, India</funding><pagination>109918</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11134565</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>27(6)</volume><pubmed_abstract>Malaria parasite invasion to host erythrocytes is mediated by multiple interactions between merozoite ligands and erythrocyte receptors that contribute toward the development of disease pathology. Here, we report a novel antigen &lt;i>Plasmodium&lt;/i> prohibitin "&lt;i>Pf&lt;/i>PHB2" and identify its cognate partner "Hsp70A1A" in host erythrocyte that plays a crucial role in mediating host-parasite interaction during merozoite invasion. Using small interfering RNA (siRNA)- and glucosamine-6-phosphate riboswitch (glmS) ribozyme-mediated approach, we show that loss of Hsp70A1A in red blood cells (RBCs) or &lt;i>Pf&lt;/i>PHB2 in infected red blood cells (iRBCs), respectively, inhibit &lt;i>Pf&lt;/i>PHB2-Hsp70A1A interaction leading to invasion inhibition. Antibodies targeting &lt;i>Pf&lt;/i>PHB2 and monoclonal antibody t</pubmed_abstract><journal>iScience</journal><pubmed_title>Targeting &lt;i>Pf&lt;/i>Prohibitin 2-Hu-Hsp70A1A complex as a unique approach towards malaria vaccine development.</pubmed_title><pmcid>PMC11134565</pmcid><funding_grant_id>IRHPA IPA/2020/000007</funding_grant_id><funding_grant_id>075-15-2022-301</funding_grant_id><pubmed_authors>Kumari G</pubmed_authors><pubmed_authors>Biswas S</pubmed_authors><pubmed_authors>Saini M</pubmed_authors><pubmed_authors>Ramalingam S</pubmed_authors><pubmed_authors>Shoaib R</pubmed_authors><pubmed_authors>Anand S</pubmed_authors><pubmed_authors>Bhowmick IP</pubmed_authors><pubmed_authors>Abdulhameed Almuqdadi HT</pubmed_authors><pubmed_authors>Ranganathan A</pubmed_authors><pubmed_authors>Marothia M</pubmed_authors><pubmed_authors>Kahlon AK</pubmed_authors><pubmed_authors>Shevtsov M</pubmed_authors><pubmed_authors>Maurya P</pubmed_authors><pubmed_authors>Garg S</pubmed_authors><pubmed_authors>Behl A</pubmed_authors><pubmed_authors>Goswami B</pubmed_authors><pubmed_authors>Munjal A</pubmed_authors><pubmed_authors>Singh S</pubmed_authors><pubmed_authors>Gupta P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Targeting &lt;i>Pf&lt;/i>Prohibitin 2-Hu-Hsp70A1A complex as a unique approach towards malaria vaccine development.</name><description>Malaria parasite invasion to host erythrocytes is mediated by multiple interactions between merozoite ligands and erythrocyte receptors that contribute toward the development of disease pathology. Here, we report a novel antigen &lt;i>Plasmodium&lt;/i> prohibitin "&lt;i>Pf&lt;/i>PHB2" and identify its cognate partner "Hsp70A1A" in host erythrocyte that plays a crucial role in mediating host-parasite interaction during merozoite invasion. Using small interfering RNA (siRNA)- and glucosamine-6-phosphate riboswitch (glmS) ribozyme-mediated approach, we show that loss of Hsp70A1A in red blood cells (RBCs) or &lt;i>Pf&lt;/i>PHB2 in infected red blood cells (iRBCs), respectively, inhibit &lt;i>Pf&lt;/i>PHB2-Hsp70A1A interaction leading to invasion inhibition. Antibodies targeting &lt;i>Pf&lt;/i>PHB2 and monoclonal antibody t</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2026-07-15T07:52:15.909Z</modification><creation>2026-07-01T03:07:53.248Z</creation></dates><accession>S-EPMC11134565</accession><cross_references><pubmed>38812541</pubmed><doi>10.1016/j.isci.2024.109918</doi></cross_references></HashMap>